BIOMAT Database Logo BIOMAT Database Logo

Letter: 1,25-Dihydroxycholecalciferol and 1 alpha-hydroxycholecalciferol in hypoparathyroidism. 1974

A M Parfitt

UI MeSH Term Description Entries
D007011 Hypoparathyroidism A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone. Idiopathic Hypoparathyroidism,Hypoparathyroidism, Idiopathic
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol

Related Publications

A M Parfitt
1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.
July 1974, Lancet (London, England),
A M Parfitt
Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism.
May 1975, Lancet (London, England),
A M Parfitt
1,25-dihydroxycholecalciferol in hypoparathyroidism.
January 1977, Lancet (London, England),
A M Parfitt
Circulating 1,25-dihydroxycholecalciferol after intravenous injections of 1 alpha-hydroxycholecalciferol in patients on regular haemodialysis.
January 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A M Parfitt
Binding proteins for 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol.
February 1974, Journal of nutritional science and vitaminology,
A M Parfitt
Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol.
January 1976, Clinical endocrinology,
A M Parfitt
1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure.
September 1973, Lancet (London, England),
A M Parfitt
[Treatment of postoperative hypoparathyroidism with 1-alpha-hydroxycholecalciferol].
June 1978, Polskie Archiwum Medycyny Wewnetrznej,
A M Parfitt
[Treatment of hypoparathyroidism. Trials of 1 alpha-hydroxycholecalciferol (1 alpha-(OH)D3)].
August 1977, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A M Parfitt
Serum levels of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol in dogs with hypercalcaemia.
November 2004, Veterinary research communications,
Copied contents to your clipboard!